Nippon Shinyaku Co., Ltd. (NPNKF)
OTCMKTS
· Delayed Price · Currency is USD
26.60
+0.52 (1.99%)
Apr 28, 2025, 4:00 PM EDT
Nippon Shinyaku Company Description
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.
The company operates through Pharmaceuticals and Functional Food Business segments. Its Pharmaceuticals Business segment offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases.
The company’s Functional Food Business segments provides health food ingredients, preservatives, protein preparations, and sports and supplements.
The company in the Strategic Partnership with Nippon Shinyaku will develop and commercialize for Mucopolysaccharidosis.
Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.
Nippon Shinyaku Co., Ltd.
Country | Japan |
Founded | 1911 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 2,213 |
CEO | Toru Nakai |
Contact Details
Address: 14, Nishinosho-Monguchi-cho Kyoto, 601-8550 Japan | |
Phone | 81 7 5321 1111 |
Website | nippon-shinyaku.co.jp |
Stock Details
Ticker Symbol | NPNKF |
Exchange | OTCMKTS |
Stock Type | Common Stock |
Fiscal Year | April - March |
Reporting Currency | JPY |
ISIN Number | JP3717600005 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Toru Nakai | President and Director |
Takashi Takaya | GM of Personnel, General Affairs, Risk Mgmt, Compliance and Digital Trans and Director |
Shouzou Sano | MD, GM of Sales and Marketing and Director |
Koji Honma | General Manager of Personnel Dept. |
Hirokata Harada | Head of Medical Affairs Division and Corporate Officer |
Takanori Edamitsu | GM of Business Management and Sustainability and Director |
Kazuchika Takagaki | GM of Research & Development Division and Director |
Hitoshi Ishizawa | GM of Functional Food Division and Director |
Masaya Toda | Head of Licensing and Alliance Division and Corporate Officer |
Masafumi Taira | Corporate Officer and Head of Clinical Development Div. |